Stock Market News

Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows

2024.05.10 13:56

Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows

(Reuters) – About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and related conditions, a poll by Kaiser Family Foundation (KFF) showed on Friday.

The data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as Novo Nordisk (NYSE:)’s diabetes drug Ozempic or weight-loss treatment Wegovy, or Eli Lilly (NYSE:)’s obesity drug Zepbound.

WHY IT’S IMPORTANT

The poll highlights the growing popularity of the medicines, even as Eli Lilly and Novo Nordisk race to increase supply of the treatments, which have faced intermittent shortages over the past year.

BY THE NUMBERS

Awareness about the treatments has also risen, the poll showed, with about one-third of adults now saying they have heard “a lot” about these drugs, up from 19% in July last year.

Still, affordability remains a challenge. Adults with annual household incomes of $90,000 or greater were more likely than those with lower household incomes to say they have heard “a lot” about these drugs, the poll showed.

About 54% of those who have taken GLP-1 drugs found it challenging to afford them, even with insurance.

WHAT’S NEXT

The companies are working to provide clinical evidence that their drugs have medical benefits beyond diabetes and weight loss, such as lowering the risk of stroke and heart attack, which could broaden insurance coverage.

Medicare prescription drug plans administered by private insurers, known as Part D, currently cannot cover drugs that are approved solely for obesity.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.

Six in ten polled adults said Medicare should cover the cost of these drugs when prescribed for weight loss.



Source link

Related Articles

Back to top button
bitcoin
Bitcoin (BTC) $ 69,473.61 0.48%
ethereum
Ethereum (ETH) $ 2,495.81 0.85%
tether
Tether (USDT) $ 0.999833 0.17%
bnb
BNB (BNB) $ 574.35 0.91%
solana
Solana (SOL) $ 166.31 0.83%
usd-coin
USDC (USDC) $ 1.00 0.11%
xrp
XRP (XRP) $ 0.511313 1.77%
staked-ether
Lido Staked Ether (STETH) $ 2,494.81 0.79%
dogecoin
Dogecoin (DOGE) $ 0.159254 0.34%
tron
TRON (TRX) $ 0.167232 0.11%
cardano
Cardano (ADA) $ 0.356278 2.77%
the-open-network
Toncoin (TON) $ 4.92 0.97%
wrapped-steth
Wrapped stETH (WSTETH) $ 2,953.07 0.37%
shiba-inu
Shiba Inu (SHIB) $ 0.000018 0.94%
wrapped-bitcoin
Wrapped Bitcoin (WBTC) $ 69,364.58 0.27%
avalanche-2
Avalanche (AVAX) $ 24.68 1.43%
weth
WETH (WETH) $ 2,495.99 0.84%
chainlink
Chainlink (LINK) $ 11.19 1.32%
bitcoin-cash
Bitcoin Cash (BCH) $ 347.08 0.47%
usds
USDS (USDS) $ 1.00 0.40%
leo-token
LEO Token (LEO) $ 6.07 0.39%
polkadot
Polkadot (DOT) $ 3.90 1.21%
sui
Sui (SUI) $ 1.93 0.46%
litecoin
Litecoin (LTC) $ 70.61 2.64%
near
NEAR Protocol (NEAR) $ 3.94 1.04%
aptos
Aptos (APT) $ 8.71 2.71%
wrapped-eeth
Wrapped eETH (WEETH) $ 2,625.13 0.46%
uniswap
Uniswap (UNI) $ 7.43 4.93%
pepe
Pepe (PEPE) $ 0.000009 1.96%
internet-computer
Internet Computer (ICP) $ 7.83 0.92%
bittensor
Bittensor (TAO) $ 456.54 2.00%
dai
Dai (DAI) $ 0.999773 0.14%
fetch-ai
Artificial Superintelligence Alliance (FET) $ 1.21 4.71%
kaspa
Kaspa (KAS) $ 0.115552 2.36%
monero
Monero (XMR) $ 155.87 1.56%
ethena-usde
Ethena USDe (USDE) $ 1.00 0.06%
stellar
Stellar (XLM) $ 0.092419 0.13%
ethereum-classic
Ethereum Classic (ETC) $ 18.36 0.30%
whitebit
WhiteBIT Coin (WBT) $ 18.96 0.36%
first-digital-usd
First Digital USD (FDUSD) $ 0.998749 0.33%
polygon-ecosystem-token
POL (ex-MATIC) (POL) $ 0.31676 0.56%
blockstack
Stacks (STX) $ 1.59 0.80%
okb
OKB (OKB) $ 38.08 0.24%
dogwifcoin
dogwifhat (WIF) $ 2.20 4.83%
aave
Aave (AAVE) $ 141.09 1.50%
filecoin
Filecoin (FIL) $ 3.47 0.61%
arbitrum
Arbitrum (ARB) $ 0.518133 2.40%
crypto-com-chain
Cronos (CRO) $ 0.07305 0.53%
mantle
Mantle (MNT) $ 0.576028 0.39%
optimism
Optimism (OP) $ 1.50 6.32%